Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL

This study has been completed.
Information provided by:
Iladevi Cataract and IOL Research Center Identifier:
First received: March 3, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
The purpose of this study what to evaluate if axial myopia might influence the development of PCO.

Condition Intervention
Posterior Capsule Opacification
Procedure: Phaco

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Prospective Evaluation of Posterior Capsule Opacification in Myopic Eyes 4 Years After AcrySof Single-Piece IOL Implantation

Further study details as provided by Iladevi Cataract and IOL Research Center:

Primary Outcome Measures:
  • the percentage area of PCO with posterior capsule opacity (POCO) software [ Time Frame: 4 years ]

Secondary Outcome Measures:
  • the presence of PCO within the central 3-mm zone were noted [ Time Frame: 4 years ]

Enrollment: 100
Study Start Date: July 2003
Study Completion Date: November 2008
Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1. MYOPIA
axial length > 26.00 mm
Procedure: Phaco
AcrySof Single-Piece IOL
Other Names:
  • emmetropic eyes
  • normal axial length
Active Comparator: 2. Emmetropia
emmetropic eyes- eyes with an axial length of 21.00 to 23.99 mm
Procedure: Phaco
AcrySof Single-Piece IOL
Other Names:
  • emmetropic eyes
  • normal axial length

Detailed Description:
We sought to prospectively compare PCO in eyes with myopia in relation to axial length with PCO in eyes with normal axial length, to decipher the role of axial myopia in PCO 4 years after surgery for senile cataract.

Ages Eligible for Study:   50 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • local residency and presence of a cataract in an otherwise normal eye.
  • Patients older than 50 years
  • a dilated pupil after mydriasis
  • Patients with retinochoroidal atrophy, retinal laser prophylaxis,
  • hypertension

Exclusion Criteria:

  • nondilating pupil after maximal dilation;
  • pseudoexfoliation; mature, traumatic, black, or complicated cataracts;
  • previous intraocular surgery;
  • previous surgery for glaucoma;
  • uveitis
  • diabetes mellitus
  • Patients who did not give consent preoperatively
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00855491

Raghudeep Eye Clinic
Ahmedabad, gUJARAT, India, 52
Sponsors and Collaborators
Iladevi Cataract and IOL Research Center
Principal Investigator: ALPESH SHAH, MS Iladevi Cataract and IOL Research Center